Hangzhou Huabio Biotechnology Co., Ltd. was established in 2007, with its headquarters in Hangzhou, Zhejiang. The company is committed to providing high - quality biological reagent products and solutions for scientists in the global life sciences field, in vitro diagnostics, and the biomedical field.
      The company uses a series of patented technologies and processes, such as antigen design based on structural biology, recombinant antibody development through monoclonal B - cell screening, and a multi - dimensional quality verification system, to research and produce core antibody products with high sensitivity, high specificity, and no batch - to - batch differences, solving the long - standing pain points of traditional antibody processes. A scientist team composed of multiple doctors focuses on antibody discovery and antibody verification, continuously improving the technical level of antibody R & D and application.
      Our customers are spread across major universities and research institutions at home and abroad, including Ivy League schools like Harvard, MIT, and Stanford in the United States, as well as domestic institutions like Tsinghua University, Peking University, and Zhejiang University, and professional institutions like HHMI, NIH, and the Chinese Academy of Sciences. The company shoulders the mission of "Providing high - quality products and services to promote the development of life sciences" and uses its products to help scientists overcome difficulties and contribute to the publication of research results in top - tier journals such as Science, Nature, Immunity, and Cell. The company is a national high - tech enterprise, a high - tech enterprise R & D center in Zhejiang Province, has passed ISO9001 and ISO13485 quality system certifications, and owns dozens of technological invention and utility model patents and various honors.